Puma Biotechnology
(PBYI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,001 | -13,538 | -16,933 | -75,595 | -64,396 |
| Depreciation Amortization | 7,085 | 4,153 | 1,916 | 8,077 | 6,178 |
| Accounts receivable | 1,759 | 4,909 | -2,646 | -8,123 | -6,409 |
| Accounts payable and accrued liabilities | -6,655 | -7,416 | -1,928 | -1,526 | -11,628 |
| Other Working Capital | 17,222 | -5,464 | -5,430 | 23,283 | 25,136 |
| Other Operating Activity | 31,998 | 22,044 | 13,481 | 76,260 | 71,929 |
| Operating Cash Flow | $6,408 | $4,688 | $-11,540 | $22,376 | $20,810 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23 | -12 | N/A | -306 | N/A |
| Purchase Of Investment | -24,430 | -16,376 | N/A | -127,198 | -127,072 |
| Sale Of Investment | 57,033 | 51,546 | 34,377 | 132,667 | 132,667 |
| Purchase Sale Intangibles | -10,000 | -10,000 | N/A | N/A | 0 |
| Other Investing Activity | -10,000 | -10,000 | 0 | 0 | 0 |
| Investing Cash Flow | $22,580 | $25,158 | $34,377 | $5,163 | $5,595 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 8,444 | 8,444 | N/A | 25,000 | 25,000 |
| Debt Repayment | -8,444 | -8,444 | N/A | -80,000 | -80,000 |
| Common Stock Issued | 45 | 2 | N/A | 1,351 | 1,352 |
| Other Financing Activity | 0 | 0 | 0 | -13,418 | -13,418 |
| Financing Cash Flow | $45 | $2 | $N/A | $-67,067 | $-67,066 |
| Beginning Cash Position | 73,210 | 73,210 | 73,210 | 112,738 | 112,738 |
| End Cash Position | 102,243 | 103,058 | 96,047 | 73,210 | 72,077 |
| Net Cash Flow | $29,033 | $29,848 | $22,837 | $-39,528 | $-40,661 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,408 | 4,688 | -11,540 | 22,376 | 20,810 |
| Capital Expenditure | -23 | -12 | N/A | -306 | 0 |
| Free Cash Flow | 6,385 | 4,676 | -11,540 | 22,070 | 20,810 |